Skip to main content Accessibility help

Dietary supplementation with n-3 PUFA does not promote weight loss when combined with a very-low-energy diet

  • Irene A. Munro (a1) and Manohar L. Garg (a1)

Obesity is associated with elevated levels of inflammation and metabolic abnormalities which are linked to CVD. The aim of the present study was to investigate whether long-chain n-3 PUFA (LCn-3PUFA), combined with a very-low-energy diet (VLED), facilitated weight loss and weight maintenance, and improvements in blood lipids and inflammatory mediators. This was a double-blind, randomised, controlled trial with two parallel groups. For 14 weeks, one group consumed 6 × 1 g capsules/d of monounsaturated oil (placebo group, PB), and the other group consumed 6 × 1 g capsules/d of LCn-3PUFA (fish oil group, FO), each comprising 70 mg EPA and 270 mg DHA. Both groups were on VLED for 4 weeks (n 14 PB, n 18 FO), which was then followed by 10 weeks of weight maintenance (n 12 PB, n 17 FO). Fasting blood samples, anthropometric measurements and 3 d food diaries were collected at baseline, at 4 and 14 weeks. A greater-than-2-fold increase occurred in plasma levels of EPA and DHA in the FO group (P < 0·001). At 4 weeks, the mean weight loss was − 6·54 (sd 2·08) kg ( − 6·9 %) for PB and − 6·87 (sd 1·83) kg ( − 7·7 %) for FO. At week 14, after the maintenance phase, there was a further mean decrease in weight, − 1·57 (sd 3·7) kg (1·85 %) for PB and − 1·69 (sd 2·32) kg ( − 1·9 %) for FO. Both groups experienced improved metabolic profiles and there was a significant reduction in fat mass for the FO group at week 14 but not for PB. However, it would appear that supplementation with LCn-3PUFA had no significant effect on weight loss or weight maintenance over the 14 weeks.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Dietary supplementation with n-3 PUFA does not promote weight loss when combined with a very-low-energy diet
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Dietary supplementation with n-3 PUFA does not promote weight loss when combined with a very-low-energy diet
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Dietary supplementation with n-3 PUFA does not promote weight loss when combined with a very-low-energy diet
      Available formats
Corresponding author
*Corresponding author: Professor M. L. Garg, fax +61 2 4921 2028, email
Hide All
1Fruhbeck, G (2007) Vasoactive factors and inflammatory mediators produced in adipose tissue. In Adipose Tissue and Adipokines in Health and Disease, pp. 6377 [, editors]. Totowa: Human Press, Inc.
2NCEP (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 31433421.
3Weisberg, SP, McCann, D, Desai, M, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 17961808.
4Blake, GJ & Ridker, PM (2001) High sensitivity C-reactive protein for predicting cardiovascular disease: an inflammatory hypothesis. Eur Heart J 22, 349352.
5Lau, DC, Dhillon, B, Yan, H, et al. (2005) Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 288, H2031H2041.
6Blake, GJ & Ridker, PM (2001) Novel clinical markers of vascular wall inflammation. Circ Res 89, 763771.
7Nesto, RW (2005) Obesity: a major component of the metabolic syndrome. Tex Heart Inst J 32, 387389.
8Jellema, A, Plat, J & Mensink, RP (2004) Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur J Clin Invest 34, 766773.
9Krebs, JD, Browning, LM, McLean, NK, et al. (2006) Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int J Obes (Lond) 30, 15351544.
10Williamson, DF (1997) Intentional weight loss: patterns in the general population and its association with morbidity and mortality. Int J Obes Relat Metab Disord 21, Suppl. 1, S14S19, discussion S20–S11.
11Calder, PC (2002) Dietary modification of inflammation with lipids. Proc Nutr Soc 61, 345358.
12Harris, WS (1989) Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 30, 785807.
13Belalcazar, LM, Reboussin, DM, Haffner, SM, et al. (2010) Marine omega-3 fatty acid intake: associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care 33, 197199.
14Gunnarsdottir, I, Tomasson, H, Kiely, M, et al. (2008) Inclusion of fish or fish oil in weight-loss diets for young adults: effects on blood lipids. Int J Obes (Lond) 32, 11051112.
15Harris, WS (1996) n-3 Fatty acids and lipoproteins: comparison of results from human and animal studies. Lipids 31, 243252.
16Nakatani, T, Kim, HJ, Kaburagi, Y, et al. (2003) A low fish oil inhibits SREBP-1 proteolytic cascade, while a high-fish-oil feeding decreases SREBP-1 mRNA in mice liver: relationship to anti-obesity. J Lipid Res 44, 369379.
17Ruzickova, J, Rossmeisl, M, Prazak, T, et al. (2004) Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids 39, 11771185.
18Buckley, JD & Howe, PR (2009) Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids. Obes Rev 10, 648659.
19Blackburn, G (1995) Effect of degree of weight loss on health benefits. Obes Res 3, Suppl. 2, 211s216s.
20Klein, S (2001) Outcome success in obesity. Obes Res 9, Suppl. 4, 354S358S.
21Kellet, E, Smith, AE & Schmerlaib, Y (1998) The Australian Guide to Healthy Eating. Canberra: Australian Government Department of Health and Ageing.
22Lepage, G & Roy, CC (1986) Direct transesterification of all classes of lipids in a one step reaction. J Lipid Res 27, 114120.
23Rothacker, DQ & Watemberg, S (2004) Short-term hunger intensity changes following ingestion of a meal replacement bar for weight control. Int J Food Sci Nutr 55, 223226.
24Raclot, T, Groscolas, R, Langin, D, et al. (1997) Site-specific regulation of gene expression by n-3 polyunsaturated fatty acids in rat white adipose tissues. J Lipid Res 38, 19631972.
25Minami, A, Ishimura, N, Sakamoto, S, et al. (2002) Effect of eicosapentaenoic acid ethyl ester v. oleic acid-rich safflower oil on insulin resistance in type 2 diabetic model rats with hypertriacylglycerolaemia. Br J Nutr 87, 157162.
26Kunesova, M, Braunerova, R, Hlavaty, P, et al. (2006) The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiol Res 55, 6372.
27Thorsdottir, I, Tomasson, H, Gunnarsdottir, I, et al. (2007) Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content. Int J Obes (Lond) 31, 15601566.
28DeFina, LF, Marcoux, LG, Devers, SM, et al. (2011) Effects of omega-3 supplementation in combination with diet and exercise on weight loss and body composition. Am J Clin Nutr 93, 455462.
29Couet, C, Delarue, J, Ritz, P, et al. (1997) Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int J Obes Relat Metab Disord 21, 637643.
30Kabir, M, Skurnik, G, Naour, N, et al. (2007) Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr 86, 16701679.
31Colomer, R, Moreno-Nogueira, JM, Garcia-Luna, PP, et al. (2007) N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr 97, 823831.
32Klein-Platat, C, Drai, J, Oujaa, M, et al. (2005) Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr 82, 11781184.
33Karlsson, M, Marild, S, Brandberg, J, et al. (2006) Serum phospholipid fatty acids, adipose tissue, and metabolic markers in obese adolescents. Obesity (Silver Spring) 14, 19311939.
34Micallef, M, Munro, I, Phang, M, et al. (2009) Plasma n-3 polyunsaturated fatty acids are negatively associated with obesity. Br J Nutr 102, 13701374.
35Astrup, A & Rossner, S (2000) Lessons from obesity management programmes: greater initial weight loss improves long-term maintenance. Obes Rev 1, 1719.
36McGuire, MT, Wing, RR, Klem, ML, et al. (1999) What predicts weight regain in a group of successful weight losers? J Consult Clin Psychol 67, 177185.
37Anderson, JW, Konz, EC, Frederich, RC, et al. (2001) Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr 74, 579584.
38Boden, WE (2000) High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am J Cardiol 86, 19L22L.
39Poobalan, A, Aucott, L, Smith, WC, et al. (2004) Effects of weight loss in overweight/obese individuals and long-term lipid outcomes – a systematic review. Obes Rev 5, 4350.
40Dattilo, AM & Kris-Etherton, PM (1992) Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 56, 320328.
41Ditschuneit, HH, Flechtner-Mors, M, Johnson, TD, et al. (1999) Metabolic and weight-loss effects of a long-term dietary intervention in obese patients. Am J Clin Nutr 69, 198204.
42Balk, EM, Lichtenstein, AH, Chung, M, et al. (2006) Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 189, 1930.
43Micallef, MA & Garg, ML (2008) The lipid-lowering effects of phytosterols and (n-3) polyunsaturated fatty acids are synergistic and complementary in hyperlipidemic men and women. J Nutr 138, 10861090.
44Micallef, MA & Garg, ML (2009) Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals. Atherosclerosis 204, 476482.
45Connor, WE (1968) Dietry sterols: their relationship to atherosclerosis. J Am Diet Assoc 52, 202208.
46Harris, WS & Bulchandani, D (2006) Why do omega-3 fatty acids lower serum triglycerides? Curr Opin Lipidol 17, 387393.
47Anubhuti, & Arora, S (2008) Leptin and its metabolic interactions: an update. Diabetes Obes Metab 10, 973993.
48Boden, G, Chen, X, Mozzoli, M, et al. (1996) Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 81, 34193423.
49Maffei, M, Halaas, J, Ravussin, E, et al. (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1, 11551161.
50Kolaczynski, JW, Considine, RV, Ohannesian, J, et al. (1996) Responses of leptin to short-term fasting and refeeding in humans: a link with ketogenesis but not ketones themselves. Diabetes 45, 15111515.
51Mori, TA, Burke, V, Puddey, IB, et al. (2004) Effect of fish diets and weight loss on serum leptin concentration in overweight, treated-hypertensive subjects. J Hypertens 22, 19831990.
52Puglisi, MJ, Hasty, AH & Saraswathi, V (2011) The role of adipose tissue in mediating the beneficial effects of dietary fish oil. J Nutr Biochem 22, 101108.
53Selvin, E, Paynter, NP & Erlinger, TP (2007) The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med 167, 3139.
54Tsitouras, PD, Gucciardo, F, Salbe, AD, et al. (2008) High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults. Horm Metab Res 40, 199205.
55Madsen, T, Christensen, JH, Blom, M, et al. (2003) The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose–response study. Br J Nutr 89, 517522.
56Puglisi, MJ & Fernandez, ML (2008) Modulation of C-reactive protein, tumor necrosis factor-alpha, and adiponectin by diet, exercise, and weight loss. J Nutr 138, 22932296.
57Caughey, GE, Mantzioris, E, Gibson, RA, et al. (1996) The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63, 116122.
58Skulas-Ray, AC, Kris-Etherton, PM, Harris, WS, et al. (2011) Dose–response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr 93, 243252.
59Madsen, EL, Rissanen, A, Bruun, JM, et al. (2008) Weight loss larger than 10 % is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. Eur J Endocrinol 158, 179187.
60Attie, AD, Krauss, RM, Gray-Keller, MP, et al. (2002) Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J Lipid Res 43, 18991907.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed